SAN DIEGO, CA — Sift Biosciences will be presenting at the 2026 BIO International Convention in San Diego. CEO and Co-Founder Dr. Yue Clare Lou will pitch Sift at Startup Stadium, hosted by California Life Sciences (CLS), on Tuesday, June 23, 2026 from 11:55 AM – 12:05 PM in the Oncology track (room 5B).
“I’ll be at the 2026 BIO International Convention in San Diego, presenting at Startup Stadium — thanks, California Life Sciences (CLS), for the opportunity,” said Dr. Lou. “I will be meeting with pharma, VCs, and selected vendors on partnership opportunities and our upcoming Seed raise. DM me or book through the BIO Partnering portal if you’d like to chat!”
Presentation Details
Event: 2026 BIO International Convention — Startup Stadium
Date: Tuesday, June 23, 2026
Time: 11:55 AM – 12:05 PM
Track: Oncology
Room: 5B
About Sift Biosciences
Sift Biosciences is a preclinical immunotherapy company developing “T-cell booster” peptides designed to amplify immune responses in cancers and other immune diseases where current therapies fail. Founded in 2024 as a UC Berkeley spin-out, Sift combines AI, metagenomics, and high-throughput immune profiling to identify peptides capable of harnessing pre-existing immune memory for faster, safer, and more effective treatments. The company’s initial focus is on gastrointestinal and gynecologic cancers, with an expanding pipeline in autoimmunity.